Company: NGVT
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0001653477-25-000091
Chunk: 100

Company: Ingevity Corp
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 8
Chunk 100
---
 (1)$12.3 $62.8 _______________(1) See Note 11 for more information. 

Acquisition-related costs

Three Months Ended March 31, 2025 vs. 2024 

Acquisition-related (income) costs were zero and $0.3 million for the three months ended March 31, 2025 and 2024, respectively. All charges relate to the integration of Ozark Materials into our Performance Chemicals reportable segment. 

32

Other (income) expense, net

Three Months Ended March 31, 2025 vs. 2024Three Months Ended March 31,In millions20252024Foreign currency transaction (gain) loss $(1.4)$1.4 Loss on CTO resales (1)— 26.5 (Gain) loss on strategic investments (2)— 4.8 Proxy contest charges (3)7.9 — Other (income) expense, net(2.4)(0.5)Total Other (income) expense, net$4.1 $32.2 _______________

(1) See Notes 11 and 14 for more information.

(2) See Note 4 for more information.

(3) See Note 14 for more information.

Interest expense, net

Three Months Ended March 31, 2025 vs. 2024

Three Months Ended March 31,In millions20252024Accounts receivable securitization (1)$0.7 $1.4 Finance lease obligations (1)1.8 1.8 Interest rate swap (2)(0.2)— Litigation related interest expense (3)1.3 1.3 Revolving Credit Facility and other lines of credit (1)11.4 13.2 Senior notes (1)5.6 5.6 Other interest (income) expense, net(1.2)(1.0)Total Interest expense, net$19.4 $22.3 

_______________

(1) See Note 9 for more information.

(2) See Note 8 for more information.

(3) See Note 13 for more information. 

Provision (benefit) for income taxes

Three Months Ended March 31, 2025 vs. 2024

For the three months ended March 31, 2025 and 2024, our effective tax rate was